Improving predictions for liver cancer outcomes
Improved early prognostic algorithm for hepatocellulcar carcinoma
['FUNDING_CAREER'] · JOHNS HOPKINS UNIVERSITY · NIH-10795840
This study is looking to create a better way to predict how well patients with liver cancer will do, especially those who might need a liver transplant, by checking different tests and factors that could affect their health.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10795840 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a more accurate prognostic algorithm for patients with hepatocellular carcinoma (HCC), particularly those eligible for liver transplantation. By examining various imaging techniques, clinical factors, and blood-based biomarkers, the study aims to identify key determinants that influence patient outcomes. Participants will be monitored until they undergo transplantation or experience disease progression, allowing for a tailored approach to their treatment. The research also explores the potential of liquid biopsies to provide insights into cancer progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with hepatocellular carcinoma who are listed for liver transplantation.
Not a fit: Patients with liver cancer who are not eligible for transplantation or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment plans for liver cancer patients, improving their chances of survival and quality of life.
How similar studies have performed: Previous research has shown promise in using imaging and biomarkers for cancer prognosis, suggesting that this approach could yield significant advancements.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KIM, AMY K — JOHNS HOPKINS UNIVERSITY
- Study coordinator: KIM, AMY K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer, Epithelial cancer